Table 2.
Baseline Clinical Characteristics by Randomization Group
| Characteristica | Traditional CR n = 92 | Tailored CR n = 133 |
|---|---|---|
| Systolic blood pressure, mm Hg | 130 ± 17 | 125 ± 19 |
| Diastolic blood pressure, mm Hg | 73 ± 11 | 71 ± 10 |
| Resting heart rate, bpm | 71 ± 10 | 71 ± 11 |
| HDL-C, mg/dLb | 44 ± 14 | 46 ± 14 |
| LDL-C, mg/dL | 91 ± 33 | 87 ± 32 |
| Triglycerides, mg/dL | 161 ± 78 | 146 ± 74 |
| Fasting glucose, mg/dL | 106 ± 31 | 109 ± 32 |
| Percent body fat | 37 ± 6 | 37 ± 6 |
| Body mass index, kg/m2 | 31 ± 7 | 31 ± 7 |
| Weight, pounds | 179 ± 41 | 180 ± 43 |
| Waist circumference, cm | 100 ± 15 | 100 ± 16 |
| Pack years smoked | 16 ± 22 | 18 ± 25 |
| Urine cotinine, ng/mL | 159 ± 383 | 102 ± 255 |
| Peak exercise capacity, METS | 5 ± 2 | 6 ± 3 |
| Peak treadmill time, minutes | 8 ± 3 | 8 ± 4 |
| Medications, n (%) | ||
| Statins | 83 (90) | 117 (88) |
| Beta-blockers | 77 (84) | 108 (81) |
| Aspirin | 81 (88) | 112 (84) |
| Clopidogrel | 53 (58) | 89 (67)c |
| Angiotensin-converting enzyme inhibitor | 27 (29) | 58 (44)c |
| Antidepressant | 16 (17) | 31 (23) |
| Anxyolytic | 26 (28) | 18 (14) |
a
Continuous variables are reported as mean ± standard deviation; categorical variables are number (%).
b
To convert LDL and HDL to mmol/L, multiply by 0.0259; to convert triglycerides to mmol/L, multiply by 0.0113; to convert glucose to mmol/L, multiply by 0.0555.
c
Chi-square test and t test for discrete and continuous variables, respectively, p < 0.05.
HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; METS, metabolic equivalents.